Oregon Health Science University Hospital

Portland, Oregon 97239-3098

5 studies enrolling now · 24 studies all time

What they study most

Acute Coronary Syndrome (ACS), Age-Related Cognitive Decline, Anticoagulants, Arteriovenous Fistula, Arteriovenous Fistula Occlusion, Arteriovenous Fistula Stenosis, Atrial Fibrillation, Benzodiazepine Refractory Status Epilepticus, Bicuspid Aortic Valve, Bone Neoplasms, Brain Injuries, Traumatic, CIED Related Infection

Studies at this site

• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
• International Registry for Men With Advanced Prostate Cancer (IRONMAN) — Recruiting now
• Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• Prevail Global Study — Recruiting now
• Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis — Running, not enrolling
• TTVR Early Feasibility Study — Running, not enrolling
• SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study — Running, not enrolling
• Brain Oxygen Optimization in Severe TBI, Phase 3 — Running, not enrolling
• Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — Completed
• IN.PACT™ AV Access Post-Approval Study (PAS002) — Running, not enrolling
• Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) — Completed
• Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals — Completed
• Convalescent Plasma in Outpatients With COVID-19 — Completed
• Established Status Epilepticus Treatment Trial — Completed
• Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) — Completed
• Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia — Status unconfirmed
• VITROS Immunodiagnostic Products hs Troponin I — Status unconfirmed
• Reveal LINQ™ Heart Failure — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Acute Care for Elders (ACE) Program at OHSU Hospital — Status unconfirmed
• Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 — Stopped early